Trxade Well being Inc (NASDAQ: MEDS) Monday reported a narrower web loss for the fourth quarter of 2021 because the pharmaceutical providers firm’s revenues elevated 20%.
Fourth-quarter revenues elevated 19.7% year-over-year to $2.4 million and got here in above analysts’ estimates. The corporate added 175 registered members throughout the three-month interval.
Trxade reported a web lack of $0.8 million or $0.10 per share for the fourth quarter, which marked an enchancment from the $2.3 million or $0.29 per share loss reported within the year-ago quarter. The underside line additionally beat analysts’ estimates.
Verify this area to learn administration/analysts’ feedback on Trxade’s This fall 2021 outcomes
Shares of Trxade closed Monday’s buying and selling greater and continued to realize within the prolonged session, quickly after the earnings announcement. The inventory has misplaced about 55% prior to now six months.